Resources
Common myths about clinical trials
Much of what you hear about cancer clinical trials is outdated or simply incorrect. That holds whether you are looking into a study for yourself or reading on behalf of someone in your family. Five common myths follow.
Updated
Myth: once you sign, you cannot leave
Signing the consent document does not create a contract. Whatever the reason, you can withdraw from a cancer study whenever you choose.
Myth: studies are only for people who are out of options
Cancer clinical trials are open to people at many stages of the condition. Some studies also enroll people who do not have it at all.
Myth: nobody is watching out for participants
An independent committee reviews every study before it begins and keeps reviewing it while it runs. See how studies are reviewed and monitored.
Myth: you will not be told what is going on
The details of a cancer study reach you in writing first, before you agree to anything. The team's obligation continues after that. Should something new come to light that could alter the choice you made, they have to tell you.
Myth: taking part means giving up your own doctor
Most cancer studies leave you with your own doctor. Make sure that doctor and the study team each know about the other.
Talk with a study coordinator
A coordinator can explain which studies may fit and what the next step looks like. To reach one, call (888) 343-1186 or send a short form, whether for yourself or for a family member. Asking questions commits you to nothing.
Sources and further reading
- About Research Participation — HHS Office for Human Research Protections
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Clinical Trials — MedlinePlus (National Library of Medicine)